search
Back to results

Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition

Primary Purpose

Malnutrition; Moderate

Status
Unknown status
Phase
Phase 4
Locations
Nigeria
Study Type
Interventional
Intervention
Standardized milk-based formulation
Sponsored by
Dr. Ekong E. Udoh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Malnutrition; Moderate focused on measuring Nutrition, Formulations, Moderate, Malnutrition, Underfives

Eligibility Criteria

6 Months - 59 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Children aged 6 - 59 months with moderate acute malnutrition (weight-for-height between -2 and -3 Z scores or mid upper arm circumference of 11.5 cm - 12.5 cm).
  2. Children whose parents/guardian consent to their participation and agree to bring the children/wards to the health facility throughout the period of the study.

Exclusion Criteria:

  1. Children with chronic illnesses that may affect growth {(cardiac disease, renal disease, tuberculosis (chronic cough, history of contact with an adult with chronic cough, poor growth, chest infection not responding to antibiotics) liver disease, HIV/AIDS}
  2. Children with feeding difficulties eg. Gastroesophageal reflux diseases, cleft palate
  3. Children with diarrhoea
  4. Children with neurological diseases eg. Cerebral palsy
  5. Children less than 6 months or more 59 months of age

Sites / Locations

  • Primary Health Centre, Okpoediuse
  • Primary Health Centre, Adadiah
  • Primary Health centre, Mbak-Etoi

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Standardized milk-based formulation

Standardized non-milk based formulation

Hospital-based formulation

Arm Description

Formulation of maize with milk that is rich in methionine

Formulation of maize with soybeans that is rich in methionine and lysine

Formulation of maize, milk and soybeans

Outcomes

Primary Outcome Measures

weight-for-height
Improvement in weight-for-height at two weekly intervals

Secondary Outcome Measures

Recovery from moderate acute malnutrition
Proportion of children whose weight-for-height z score improved from <-2 to ≥ 2
Adverse events
The number of children that develop and undesirable gastrointestinal or extraintestinal disorder

Full Information

First Posted
March 24, 2020
Last Updated
March 26, 2020
Sponsor
Dr. Ekong E. Udoh
search

1. Study Identification

Unique Protocol Identification Number
NCT04323059
Brief Title
Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition
Official Title
Effectiveness, Tolerability and Safety of Standardized Milk-based, Standardized Non-milk Based and Hospital-based Formulations in the Management of Moderate Acute Malnutrition in Underfive Children: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 2020 (Anticipated)
Primary Completion Date
October 2020 (Anticipated)
Study Completion Date
November 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Dr. Ekong E. Udoh

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a randomized clinical trial aimed at evaluating the effectiveness, tolerability and safety of standardized milk-based formulation, standardized non-milk based formulation and a hospital-based formulation in the management of children aged 6 - 59 months with moderate acute malnutrition. Eligible children will be randomized into one of the three intervention arms and given supplementary doses of the formulations at 50% of their daily caloric requirement for a period of four months based on the group of their assignment. The remainder will be obtained from their regular family diets. The clinical features, anthropometric measurements and laboratory parameters of the children will be assessed at baseline. The children will be followed up on two weekly basis for a period of four months during which further clinical assessment, anthropometric measurements and laboratory evaluations will be performed. The outcome measures will be determined based on "per protocol analysis".
Detailed Description
Childhood malnutrition is presently a leading cause of underfive morbidity and mortality globally. The impact of the condition is most severe in the first 1000 days of life with resultant impairment in physical, neurologic, immunologic and metabolic development. Undernutrition, the commoner form of childhood malnutrition, is usually classified as underweight (weight-for-age Z score < -2), stunting (height-for-age Z score <-2), wasting (weight-for-height Z score < -2) or edematous malnutrition (kwashiorkor) in relation to the World Health Organization standard reference values for age and sex. It is further sub-classified into severe acute malnutrition (SAM) wherein z score is <-3 and moderate acute malnutrition (MAM) wherein z score is between -2 and -3.(1) MAM accounts for about 70.0% of all malnutrition-related childhood deaths. Children with MAM are currently managed using community-based approach. This approach entails early detection and treatment of children with MAM in the community, timely referral to inpatient care for those that progress to SAM or develop complications, and subsequent follow up in the community at discharge. MAM is usually managed by nutrition education of the caregivers on preparation of nutritious, palatable and culturally acceptable food from locally available food stuffs like banana porridge or corn gruel fortified with legume (mashed groundnut or soya bean), crayfish, palm oil, powdered milk and vegetables. The second strategy is by Ready-to-use therapeutic foods (RUTFs). (2) The main drawback of the RUTFs is that they are usually provided by external donor agencies and as such, not always available in settings where childhood malnutrition is endemic. Children treated with RUTFs are therefore at risk of progressing to SAM or dying when the formulations are no longer available. There is currently no consensus on the appropriate nutritional formulation for community-based management of MAM in children in endemic regions. It is therefore imperative to evaluate the effect of readily available formulations that are comparable to the RUTFs in community-based management of childhood MAM in endemic regions. (3) The standardized milk-based formulation (SMBF), the standardized non milk-based formulation (SNMBF) and the hospital-based formulation (HBF) are examples of formulations that are readily available in the country. The SMBF consists of maize and is rich in methionine, the SNMBF consists of maize and soybeans, and is rich in methionine and lysine while the HBF consist of a combination of maize, milk and soybeans. The nutrient composition of the above-mentioned formulations is similar to that of the RUTFs, making them suitable for community-based management of MAM. However, no clinical trial has so far been conducted to evaluate their effect in managing underfive children with MAM. The cost effectiveness of the various formulations will also be assessed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition; Moderate
Keywords
Nutrition, Formulations, Moderate, Malnutrition, Underfives

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
The study participants will be randomized into three different intervention groups. Based on the group of assignment, the participants will receive either the standardized milk-based formulation, the standardized non-milk based formulation or the hospital-based formulation.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standardized milk-based formulation
Arm Type
Experimental
Arm Description
Formulation of maize with milk that is rich in methionine
Arm Title
Standardized non-milk based formulation
Arm Type
Experimental
Arm Description
Formulation of maize with soybeans that is rich in methionine and lysine
Arm Title
Hospital-based formulation
Arm Type
Active Comparator
Arm Description
Formulation of maize, milk and soybeans
Intervention Type
Dietary Supplement
Intervention Name(s)
Standardized milk-based formulation
Other Intervention Name(s)
Standardized non-milk based formulation, Hospital-based formulation
Intervention Description
Nutritional formulations prepared from locally available food stuffs for reversing childhood malnutrition
Primary Outcome Measure Information:
Title
weight-for-height
Description
Improvement in weight-for-height at two weekly intervals
Time Frame
Four months
Secondary Outcome Measure Information:
Title
Recovery from moderate acute malnutrition
Description
Proportion of children whose weight-for-height z score improved from <-2 to ≥ 2
Time Frame
Four month
Title
Adverse events
Description
The number of children that develop and undesirable gastrointestinal or extraintestinal disorder
Time Frame
Four months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
59 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children aged 6 - 59 months with moderate acute malnutrition (weight-for-height between -2 and -3 Z scores or mid upper arm circumference of 11.5 cm - 12.5 cm). Children whose parents/guardian consent to their participation and agree to bring the children/wards to the health facility throughout the period of the study. Exclusion Criteria: Children with chronic illnesses that may affect growth {(cardiac disease, renal disease, tuberculosis (chronic cough, history of contact with an adult with chronic cough, poor growth, chest infection not responding to antibiotics) liver disease, HIV/AIDS} Children with feeding difficulties eg. Gastroesophageal reflux diseases, cleft palate Children with diarrhoea Children with neurological diseases eg. Cerebral palsy Children less than 6 months or more 59 months of age
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ekong E Udoh, FWACPaed
Phone
+234(0)38355559
Email
rejoicerejoice2001@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
Sunday B Adesina
Phone
+234(0)8035036479
Email
adesinasunday08@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ekong E Udoh, FWACPaed
Organizational Affiliation
University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sunday B Adesina, FWACPaed
Organizational Affiliation
University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Blessing N Nwazuluoke, BSc
Organizational Affiliation
University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria
Official's Role
Study Chair
Facility Information:
Facility Name
Primary Health Centre, Okpoediuse
City
Ibiono Ibom
State/Province
Akwa Ibom
Country
Nigeria
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Edo Asuquo
Phone
+234(0)7064559257
First Name & Middle Initial & Last Name & Degree
Anietie Ekwere
Phone
+234(7)089721411
First Name & Middle Initial & Last Name & Degree
Ekong E Udoh, MBBS, FWACPaed
First Name & Middle Initial & Last Name & Degree
Victor E Bassey, BSc, PhD
Facility Name
Primary Health Centre, Adadiah
City
Uruan
State/Province
Akwa Ibom
Country
Nigeria
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christiana F Ekpeyong
Phone
+234(0)8067685745
First Name & Middle Initial & Last Name & Degree
Okon Asuquo
Phone
+234(0)7063384541
First Name & Middle Initial & Last Name & Degree
Ekong E Udoh, FWACPaed
First Name & Middle Initial & Last Name & Degree
Sunday B Adesina, FWACPaed
Facility Name
Primary Health centre, Mbak-Etoi
City
Uyo
State/Province
Akwa Ibom
Country
Nigeria
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eneawan Edem
Phone
+234(0)8028457047
First Name & Middle Initial & Last Name & Degree
Victoria Usen
Phone
+234(0)7030227955
First Name & Middle Initial & Last Name & Degree
Ekong E Udoh, FWACPaed
First Name & Middle Initial & Last Name & Degree
Sunday B Adesina, FWACPaed

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual patient data will be made available to other researchers by the Principal Investigator on request.
IPD Sharing Time Frame
The data will be available for two years after completion of the trial
IPD Sharing Access Criteria
Any investigator that request for it within the time frame will be given
Citations:
Citation
Seetharaman N, Chacko TV, Shankar SLR, Matthew AC. Measuring malnutrition - the roles of Z scores and the composite index of anthropometric failure. Indian Journal of Community Medicine. 2007; 32 (1): 35-39.
Results Reference
background
Citation
Vijay DW, Bhawesh RD. Ready to use therapeutic food (RUTF): An overview.. Advances in life Sciences and Health. 2015; 2 (1): 1-15.
Results Reference
background
PubMed Identifier
29258336
Citation
Choudhury N, Ahmed T, Hossain MI, Islam MM, Sarker SA, Zeilani M, Clemens JD. Ready-to-Use Therapeutic Food Made From Locally Available Food Ingredients Is Well Accepted by Children Having Severe Acute Malnutrition in Bangladesh. Food Nutr Bull. 2018 Mar;39(1):116-126. doi: 10.1177/0379572117743929. Epub 2017 Dec 19.
Results Reference
background

Learn more about this trial

Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition

We'll reach out to this number within 24 hrs